Sector pending / Miscellaneous Health And Allied Services, Not Elsewhere ClassifiedUpdated 2026-05-10 22:07 UTC

NSE/NEPHROPLUS stock hub

NSE/NEPHROPLUS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/NEPHROPLUSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

54.7B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/NEPHROPLUS

In the news

Latest news · NSE/NEPHROPLUS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E39.4

P25 n/aP50 n/aP75 n/a

Trailing P/E69

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC15.1

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/NEPHROPLUS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

128

Groups with data

Currency

INR

Showing 128 of 128 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	3,448
Employees Change	218%
Employees Change Percent	6.75
Enterprise value	INR 55.3B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Miscellaneous Health And Allied Services, Not Elsewhere Classified
Last refreshed	2026-05-10
Market cap	INR 54.7B
Price	INR 545
Price currency	INR
Rev Per Employee	2,762,247.68x
Sic	8090
Symbol	nse/NEPHROPLUS
Website	https://www.nephroplus.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.3%
EV Earnings	77.55x
EV/EBIT	39.03x
EV/EBITDA	24.06x
EV/Sales	5.81x
Forward P/E	39.39x
P/B ratio	7.63x
P/E ratio	69.01x
P/S ratio	5.74x
PEG ratio	0.77x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	14.88%
EBITDA Margin	22.99%
Gross margin	39.27%
Gross Profit	INR 3.7B
Gross Profit Growth	227.51%
Net Income	INR 713.4M
Pretax Margin	9.89%
Profit Margin	7.49%
Profit Per Employee	INR 206,894
ROIC	15.07
Roic5y	3.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue Growth	117.8x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 2.1B
Debt	INR 2.6B
Debt EBITDA	INR 1.14
Debt Equity	INR 0.36
Equity	INR 7.2B
Interest Coverage	2.32
Net Cash	INR -546.7M
Net Cash By Market Cap	INR -1
Net Debt EBITDA	INR 0.25
Net Debt Equity	INR 0.08
Tangible Book Value	INR 6.1B
Tangible Book Value Per Share	INR 335

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.24%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	549.5
All Time High	616
All Time High Change	-11.53%
All Time High Date	2026-02-27
All Time Low	446
All Time Low Change	22.19%
All Time Low Date	2025-12-19
ATR	20.78
Beta1y	0.91
Ch YTD	16.27
High	550
High52	616
High52 Date	2026-02-27
High52ch	-11.53%
Low	540.2
Low52	446
Low52 Date	2025-12-19
Low52ch	22.19%
Ma50ch	-0.82%
RSI	50.24
RSI Monthly	0
RSI Weekly	60.32
Sharpe ratio	1.04x
Sortino ratio	1.86
Total Return	-17.24%
Tr YTD	16.27
Tr1m	2.84%
Tr1w	-0.47%
Tr3m	2.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 1.4B
Operating Income Growth	8,159.6
Operating margin	14.88

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	28,370,286%
Shares Insiders	14.75%
Shares Institutions	20.08%
Shares Out	100,340,961
Shares Qo Q	5.95%
Shares Yo Y	17.24%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	91,652.5x
Bv Per Share	391.2
Ch1m	2.84
Ch1w	-0.47
Ch3m	2.75
Change	-0.01%
Change From Open	-0.15
Close	545
Days Gap	0.14
Depreciation Amortization	771,870,000
Dollar Volume	51,259,086.9
Earnings Date	2026-05-19
EBIT	INR 1.4B
EBITDA	INR 2.2B
EPS	INR 7.9
F Score	2
Fiscal Year End	March
Founded	2,009
Graham Number	263.65707
Graham Upside	-51.62
Income Tax	INR 228.4M
Is Primary Listing	1
Last Earnings Date	2026-02-10
Last Report Date	2025-12-31
Ma20	550.7
Ma20ch	-1.04%
Next Earnings Date	2026-05-19
Open	545.8
Position In Range	48.73
Price Date	2026-05-08
Price EBITDA	INR 24.98
Ptbv Ratio	9.02
Relative Volume	1.03x
Revenue	9,524,230,000x
Tax By Revenue	2.4x
Tax Rate	24.25%
Volume	94,062

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/NEPHROPLUS pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns NSE/NEPHROPLUS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+20.1%

Share of float held by funds and institutions

Insider ownership

+14.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+17.2%

Negative means the company is buying back shares.

Technical

NSE/NEPHROPLUS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.2

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/NEPHROPLUS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/NEPHROPLUS stock rating?

nse/NEPHROPLUS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/NEPHROPLUS analysis?

The full report lives at /stocks/nse/NEPHROPLUS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/NEPHROPLUS?

The latest report frames nse/NEPHROPLUS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/NEPHROPLUS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.